Myriad appoints Vishal Sikri EVP Commercial; CCO Brian Donnelly departs

MYRIAD GENETICS INC

Brian Donnelly steps down as Chief Commercial Officer effective Sept 16, 2026; remains non-executive through Sept 21, 2026 for transition.
Vishal Sikri promoted from SVP Product to EVP Commercial effective Sept 16, 2026.
Sikri brings molecular diagnostics/oncology expertise and prior commercial leadership roles.
Company reaffirms full-year 2026 financial guidance from July 30, 2026 earnings call.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.